Richard R. Barakat, Physician in Chief and Executive Director of Northwell Cancer Institute, shared a post on LinkedIn:
“Pleased to be joined today by Nick Slack of the START Center for Cancer Research for a ceremonial ribbon-cutting today to unveil Northwell-START New York-Long Island, which reflects a $5.7 million investment for a 10,000-square foot, state-of-the-art early-phase cancer clinical trial center. Located at Northwell’s outpatient R. J. Zuckerberg Cancer Center, the new center marks a transformative moment in cancer care delivery in New York by bringing cutting-edge, early-phase clinical trials in a specially designed facility to offer clinical trials directly to patients where they live and receive cancer treatment. The center features a fully dedicated research team, 14 infusion bays, six private exam rooms, a dedicated pharmacokinetic laboratory and a dedicated pharmacy with hazardous and non-hazardous compounding capabilities.
With over 800 currently active studies, the START Center for Cancer Research represents the industry’s largest global network of early phase clinical trial sites led by a team of 40 industry-leading principal investigators. The Northwell Cancer Institute site will be fully integrated into the START network. For too long, early-phase cancer research has been concentrated within select cancer centers, even as the majority of patients receive their care in community settings. With the official opening of the site, we’re helping make that possibility a reality as we transform how cancer care is delivered in the United States.”
Kai Tsao, System Chief of Solid Tumor Oncology at Northwell Health Cancer Institute, shared Richard R. Barakat’s post, adding:
“Today marks the beginning of an important collaboration between Northwell Cancer Institute and START, which will bring a portfolio of transformative and innovative early phase trials for our cancer patients!”